Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C37H40N2O6 |
Molecular Weight | 608.7233 |
Optical Activity | ( + ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CC=C(OC4=CC(C[C@@]5([H])N(C)CCC6=C5C(OC7=C(OC)C=C(CCN1C)C2=C7)=C(OC)C(OC)=C6)=CC=C4O)C=C3
InChI
InChIKey=DFOCUWZXJBAUSQ-URLMMPGGSA-N
InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(41-3)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-31-18-23(8-11-30(31)40)17-29-35-25(13-15-39(29)2)20-34(42-4)36(43-5)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1
Molecular Formula | C37H40N2O6 |
Molecular Weight | 608.7233 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium. | 2002 Feb 19 |
|
Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. | 2002 May |
|
Inhibition of Na(+),K(+)-ATPase by the extract of Stephania cephararantha HAYATA and bisbenzylisoquinoline alkaloid cycleanine, a major constituent. | 2003 Aug 1 |
|
[Determination of four alkaloids in Berberis plants by HPLC]. | 2003 Dec |
|
Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells. | 2003 Nov |
|
[Distribution of four alkaloids in plants of Berberis]. | 2004 Feb |
|
[Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866]. | 2004 Sep |
|
[Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo]. | 2005 Jun |
|
[The mechanism of apoptosis of chronic myeloid leukemia cells induced by the novel p210 bcr/abl inhibitor berbamine]. | 2006 Aug 29 |
|
Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. | 2006 Jan |
|
[Effects of berbamine on growth of leukemia cell line NB4 and its mechanism]. | 2006 Mar |
|
Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). | 2006 Sep |
|
Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation. | 2007 Apr |
|
Free radical scavenging activity and lipoxygenase inhibition of Mahonia aquifolium extract and isoquinoline alkaloids. | 2007 Jul 16 |
|
Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway. | 2007 May 5 |
|
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. | 2008 Aug |
|
Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. | 2008 Jul 15 |
|
Studies on alkaloids binding to GC-rich human survivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry. | 2008 Mar |
|
Harnessing gene expression to identify the genetic basis of drug resistance. | 2009 |
|
Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. | 2009 |
|
Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. | 2009 Apr |
|
Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. | 2009 Apr |
|
Berbamine derivatives: a novel class of compounds for anti-leukemia activity. | 2009 Aug |
|
Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. | 2009 Dec |
|
[Mechanism related to inhibition of leukemia K562 cells by berbamine]. | 2009 Jul |
|
The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. | 2009 Jul |
|
Probing the binding sites and the effect of berbamine on the structure of bovine serum albumin. | 2009 Jun |
|
A new dawn for the use of traditional Chinese medicine in cancer therapy. | 2009 Mar 20 |
|
Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. | 2009 May 4 |
|
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. | 2009 Oct 1 |
|
[Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway]. | 2009 Sep |
|
Suppression of human lung cancer cell growth and migration by berbamine. | 2010 Aug |
|
Traditional herbal medicine in far-west Nepal: a pharmacological appraisal. | 2010 Dec 13 |
|
A novel calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cells. | 2010 Jul |
|
Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. | 2010 Jul 23 |
|
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. | 2010 Jul 25 |
|
4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells. | 2010 Mar |
|
Tissue culture and generation of autotetraploid plants of Sophora flavescens Aiton. | 2010 Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 20:05:25 GMT 2023
by
admin
on
Fri Dec 15 20:05:25 GMT 2023
|
Record UNII |
V5KM4XJ0WM
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
848121
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
275182
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
C162341
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
V5KM4XJ0WM
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
121842
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
100000124515
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
207-523-5
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
DTXSID40963943
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
478-61-5
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
BERBAMINE
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | |||
|
m2425
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB32535
Created by
admin on Fri Dec 15 20:05:25 GMT 2023 , Edited by admin on Fri Dec 15 20:05:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|